<DOC>
	<DOCNO>NCT03059940</DOCNO>
	<brief_summary>The goal clinical research study offer lung cancer screening smoker want change smoking behavior . All eligible participant receive counsel offer least one form smoking cessation drug . The different form counsel treatment compare .</brief_summary>
	<brief_title>Smoking Cessation Intervention During Low Dose CT ( LDCT ) Screening Lung Cancer</brief_title>
	<detailed_description>Study Groups : If participant find eligible take part study , participant CT scan participant 's chest look sign lung cancer . Participant receive result 1-4 day scan . If abnormal area , participant refer participant 's regular doctor follow-up . No matter result , participant advise quit smoking . Participant decision-making conversation CT scan provider . Participant discus risk benefit smoke cessation , well participant expect treatment . Participant watch short ( 9 minute ) video lung cancer , CT scan , smoke cessation . This conversation last 15 minute . Participant receive referral intervention counsel quit smoking . Participant prescribed anti-smoking drug . This may either nicotine replacement therapy ( patch , gum , lozenge ) oral drug ( varenicline buproprion ) . The study doctor tell participant much participant 's anti-smoking drug participant take time . Participant also 5 smoke cessation counseling session next 12 week . Each session last 30 minute , participant set quit date , prepare participant 's quit date , discus cop skill deal smoke `` trigger '' participant 's quit date . Participant also discuss challenge participant may quit . Study Visits : Participant 3 additional study visit , 6 week , 12 week , 6 month CT scan . At study visit : - Participant complete questionnaires several topic , include depression , suicide , participant 's smoking behavior . These questionnaire take 30-45 minute total complete . - Urine and/or saliva collect routine test check participant 's cotinine , nicotine , and/or anabasine level . Cotinine chemical release participant 's body break nicotine show whether much participant recently smoke . Anabasine chemical show nicotine find blood due nicotine replacement therapy tobacco use . - Participant 's CO level measure . This investigational study . All smoke cessation drug use study FDA approve commercially available . It investigational compare . The study doctor describe design work . Up 1260 participant enrol study . All take part MD Anderson .</detailed_description>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Carbon Monoxide</mesh_term>
	<criteria>1 . Age : 18+ 2 . Reports daily nondaily smoker expire carbon monoxide ( CO ) great equal 6 part per million ( ppm ) ( less equal 5 , NicAlert Strip &gt; 2 ) . 3 . Interested treatment might change smoke behavior . 4 . Able follow verbal write instruction English complete aspect study . 5 . Provide informed consent agree assessment study procedure . 6 . Have address telephone number he/she may reach . 7 . Be participant his/her household . 8 . Following good clinical practice guideline , medically suitable one pharmacotherapies smoke cessation include NRT , bupropion varenicline , provider discretion . 9 . Willing able undergo low dose CT scan , determine radiology team , within 30 day enrollment protocol . 1 . Current enrollment plan enroll another smoking cessation program next 9 month . 2 . Plan use nicotine substitute ( i.e. , OTC prescription medication smoke cessation ) smoke cessation treatment next 9 month . 3 . Uncontrolled hypertension ( systolic blood pressure ; SBP great 180 diastolic blood pressure ; DBP great 110 ) 4 . Current use certain medication : ( 1 ) Smoking cessation med ( last 7 day ) , i.e. , Wellbutrin , Bupropion , Zyban , NRT , Chantix . 5 . A positive urine pregnancy test screening period . Women two year ' postmenopausal , tubal ligation partial full hysterectomy subject urine pregnancy test . 6 . Pregnant , breastfeed childbearing potential protect medically acceptable , effective method birth control enrol study . Medically acceptable contraceptive include : ( 1 ) approve hormonal contraceptive ( birth control pill , patch , implant injection ) , ( 2 ) barrier method ( condom diaphragm ) use spermicide , ( 3 ) intrauterine device ( IUD ) . Contraceptive measure sell emergency use unprotected sex acceptable method routine use . 7 . History hypersensitivity allergic reaction NRT , component formulation . 8 . Any medical psychiatric condition , illness , disorder , concomitant medication could compromise participant safety treatment , determine Principal Investigator and/or Study Physician . 9 . Subject consider investigator unsuitable candidate receipt smoke cessation pharmacotherapy unstable follow throughout entire duration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>Low Dose compute tomography</keyword>
	<keyword>LDCT</keyword>
	<keyword>Quitline</keyword>
	<keyword>Questionnaires</keyword>
	<keyword>Surveys</keyword>
	<keyword>Counseling</keyword>
	<keyword>Smoking cessation drug</keyword>
	<keyword>Anti-Smoking Drug</keyword>
	<keyword>Nicotine replacement therapy</keyword>
	<keyword>NRT</keyword>
	<keyword>Nicotine Patch</keyword>
</DOC>